Sheba Medical Center
| Israel | Turkey | Austria | |
| Stomach cancer surgery | from $28,500 | from $22,320 | from $30,000 |
| Gastroectomy | from $24,500 | from $18,300 | from $25,000 |
| Esophagectomy | from $14,032 | from $23,400 | from $30,000 |
| Resection of the esophagus | - | from $21,600 | - |
| Omentectomy | - | from $4,500 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Stomach cancer surgery upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stomach cancer surgery and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stomach cancer surgery journey.
Day 1 - Arrival
Day 2 - Pre-operation Consultation
Day 3 - Surgery
Day 4 to Day 7 - Post-operation
Week 1 to Week 4 - Rehabilitation
Please note that individual recovery times may vary and the timeline given is an estimate based on the majority of patients. It is important to follow the advice of your medical team for the best outcome.
Over 35 years' experience in hematology and bone marrow transplantation – Prof. Nagler pioneered reduced-intensity allogeneic transplantations at Sheba Medical Center.
Forbes-listed as one of Israel's top physicians for stomach cancer surgery – Prof. Nachmany leads the General Surgery Department at Sheba Medical Center.
Performed over 200 HIPEC procedures combined with cytoreductive surgery – Dr. Ben-YaaynDacov specializes in advanced stomach cancer treatments at Sheba Medical Center.
Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.
He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.
He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.